📄Overview
Haffkine Bio Pharamceutical Corporation Ltd. Mumbai has invited open tender bids for "Metformin HCL IP for our Pharmaceutical productionl" at Mumbai, Maharashtra — a Unclassified works on a Item Rate basis, carrying an estimated value of an estimated under ₹1 Cr (derived from the EMD, as the department didn't publish a value). Bids close on 20 June 2026. EMD is ₹65 K. Reference HBPCL/M-06/Meformin HCL IP/26-27.
🗓️Timeline
Published
15 Jun 2026
Submission opens
15 Jun 2026
Submission closes
20 Jun 2026
Bid opening
22 Jun 2026
📎Tender documents
Documents are mirrored from the source portal for reference. Live bidding and authoritative documents remain on the official portal.
📋Complete tender details
🏷️ Identification
Tender ID2026_HBPCL_1306504_2
Reference No.HBPCL/M-06/Meformin HCL IP/26-27
OrganisationHaffkine Bio Pharamceutical Corporation Ltd. Mumbai
Product categoryConsumables - Raw Materials
💰 Commercials
Estimated valueunder ₹1 Cr (est)
Form of contractItem Rate
EMD₹65,000
EMD exemptionAllowed
Tender fee₹3,900
Payment modeOnline
⚖️ Process & eligibility
Tender typeOpen Tender
CategoryWorks
No. of covers2
Bid validity90 days
Two-stage biddingNo
Withdrawal allowedYes
📍 Location & authority
LocationMumbai, Maharashtra
PIN400012
Bid opening placeHaffkine Bio Pharmaceutical Corporation Limted
Inviting authorityMaterials Manager
❓Frequently asked questions
What is this tender for?
Haffkine Bio Pharamceutical Corporation Ltd. Mumbai floated this tender for "Metformin HCL IP for our Pharmaceutical productionl" — Unclassified work, procured as a works contract on a Item Rate basis.
What is the estimated value?
The value wasn't published; based on the EMD it works out to about under ₹1 Cr.
What are the EMD and tender fee?
EMD is ₹65 K; tender fee is ₹4 K.
When do bids close?
Bids close on 20 June 2026; bids open on 22 June 2026.